Related Experiment Video
Updated: Aug 15, 2026

08:51
Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic
Published on: September 4, 2012
Prolactin-Linked Plasma Cell-Macrophage Immune Phenotype in Synchronous Bilateral Plasma Cell Mastitis: A Two-Center
Weili Chen1, Mengting Li1, Jiamei Feng2
1Department of Breast Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
International Journal of Women'S Health
|August 14, 2026
Summary
Synchronous bilateral plasma cell mastitis (PCM) is linked to a prolactin (PRL)-centered immune profile, suggesting a systemic phenotype. This finding may help identify patients with bilateral breast disease.
Area of Science:
- Breast disease research
- Immunology
- Endocrinology
Background:
- Plasma cell mastitis (PCM) is a chronic inflammatory breast condition.
- Bilateral PCM occurs in about 20% of cases, but its underlying cause (local vs. systemic) is unclear.
Purpose of the Study:
- Investigate if bilateral PCM is associated with a specific immune profile centered around prolactin (PRL).
- Develop a biomarker model to identify patients with bilateral PCM.
Main Methods:
- Retrospective study of 330 PCM patients (300 for development, 40 for external validation).
- Used LASSO and logistic regression to select predictors, comparing five machine learning algorithms.
- Performed immunohistochemistry for CD38, CD138, and CD68 on breast tissue.
Main Results:
- A five-variable model (including PRL) achieved high discrimination (AUCs 0.838 and 0.805).
- Prolactin (PRL) was the key predictor, showing a non-linear contribution.
- Bilateral PCM cases had higher tissue immune cell markers (CD38, CD138, CD68) and PRL levels correlated with these markers.
Conclusions:
- Synchronous bilateral PCM is linked to a dual immune pattern involving circulating PRL and local immune cells.
- This suggests bilateral PCM may represent a systemic immune issue, not just extensive local disease.
- Further validation and mechanistic studies are recommended.
Keywords:
bilateral involvementimmunoendocrineimmunohistochemistrymachine learningplasma cell mastitisprediction modelprolactin
